Timing of carotid surgery or stenting after a symptomatic carotid event

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with symptomatic extracranial carotid stenosis (50–99%) and an MRI showing acute infarction in the relevant vascular territory are assigned to receive carotid endarterectomy or carotid artery stenting plus best medical therapy either within 48 hours or after 14 days. Eligibility requires recent symptoms within 180 days, a qualifying degree of stenosis by CTA/MRA/DSA using NASCET criteria, and an mRS <3. The trial compares safety outcomes (procedural stroke, death, or complications) and efficacy (prevention of recurrent ischemic events) between the early and delayed revascularization groups. Procedures are performed at Xuanwu Hospital with standard perioperative medical management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years;
* Diagnosed with symptomatic carotid stenosis, defined as the occurrence of sudden-onset neurological symptoms within the territory of the responsible artery within 180 days before randomization (e.g., contralateral hemiparesis, slurred speech/difficulty in expression, ipsilateral monocular vision loss, etc.);
* Stenosis located in the extracranial segment of the internal carotid artery (with or without involvement of the adjacent common carotid artery);
* Degree of stenosis in the responsible carotid artery confirmed to be ≥50% and ≤99% by CTA/MRA/DSA, based on NASCET criteria;
* Brain MRI within 72 hours before randomization indicating an acute infarction in the responsible vascular territory, characterized by high signal on DWI and low signal on ADC;
* Modified Rankin Scale (mRS) score \<3;
* Written informed consent obtained from the patient or their legal representative.

Exclusion Criteria:

* Progressive neurological deterioration within 72 hours before randomization, defined as an increase in mRS score by ≥2 points or NIHSS score by ≥4 points;
* Brain MRI within 72 hours before randomization indicating a large infarction (infarct size \> 1/2 of the middle cerebral artery territory);
* MRI evidence of hemorrhagic cerebrovascular diseases (e.g., brain tumor, brain abscess, vascular malformations) or other non-ischemic cerebrovascular diseases (e.g., multiple sclerosis);
* Non-atherosclerotic carotid stenosis (e.g., carotid artery dissection, carotid web, floating thrombus, fibromuscular dysplasia, Takayasu arteritis, etc.);
* Need for simultaneous surgical intervention for tandem lesions in the ipsilateral carotid artery or other vascular surgeries;
* History of cerebrovascular surgery within 6 months before randomization;
* Coexisting cerebrovascular stenosis requiring revascularization within 3 months after randomization;
* History of spontaneous intracranial hemorrhage within 12 months before randomization;
* Clear indication for anticoagulation therapy (suspected cardiac embolic source such as atrial fibrillation, known mechanical heart valve, or suspected infective endocarditis);
* Laboratory abnormalities, including white blood cell count \< 2×10⁹/L, hematocrit \< 30%, platelet count \< 100×10⁹/L, INR \> 1.5, or heparin-induced thrombocytopenia;
* Inability to use antiplatelet therapy due to specific reasons, such as active gastrointestinal ulcers, gastrointestinal bleeding within the past 3 months, known severe allergy, severe renal insufficiency (creatinine \>1.5 times the normal upper limit), hepatic dysfunction (ALT or AST \>2 times the normal upper limit), or severe heart failure (NYHA Class III-IV);
* Presence of other severe diseases that may affect adherence to the study protocol, such as severe infection, advanced chronic obstructive pulmonary disease (COPD), active malignant tumors, dementia, psychiatric disorders, or uncontrolled severe hypertension;
* Pregnant or breastfeeding women who are not in menopause;
* Participation in another investigational device or drug trial that may interfere with this study;
* Any other medical condition or history that, in the investigator's judgment, may affect the efficacy or safety assessment of the study.

Where it's running

• Xuanwu Hospital, Capital Medical University.
  Beijing, China Recruiting

Study contacts

• Study coordinator: Yan Prof. Ma, MD
• Email: xrqssq@126.com
• Phone: +86 15001376121

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Monitoring brain oxygen levels during carotid artery surgery

  This study is testing if monitoring brain oxygen levels during carotid artery surgery can help reduce the risk of strokes and other complications for patients.

  Recruiting at 2 sites Beijing Tiantan Hospital · Beijing, Beijing Municipality and 1 other locations · NCT06406842

• Monitoring brain oxygen levels to understand postoperative delirium in carotid surgery

  This study is testing if monitoring brain oxygen levels during carotid surgery can help predict if older patients will experience confusion after the operation.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT05198635

• Evaluating factors predicting neurologic deficits during carotid endarterectomy with regional anesthesia

  This study looks at patients having carotid endarterectomy to see what factors might lead to nerve problems during the surgery when using regional anesthesia.

  Recruiting Universidade do Porto · Porto · NCT04347785

• Carotid artery stent for people with carotid narrowing who are high risk for surgery

  This study will try a carotid artery stent system in adults with carotid artery narrowing who are considered high risk for carotid endarterectomy.

  Recruiting at 16 sites Beijing Tiantan Hospital · Beijing, Beijing Municipality and 15 other locations · NCT07370246

• High-coverage carotid stent versus medical treatment to prevent embolism from symptomatic non-stenotic carotid disease (SyNC)

  This trial will test whether placing a high‑coverage carotid stent, compared with medical therapy alone, reduces repeat embolic events in people who recently had symptoms from low‑grade (10–49%) carotid plaques with high‑risk features.

  Recruiting Acandis GmbH · Solingen, North Rhine-Westphalia · NCT07166731

• Non-invasive continuous blood pressure monitoring during carotid endarterectomy

  This test will see if a non-invasive digital cuff can continuously track blood pressure as accurately as an arterial catheter in adults having carotid endarterectomy under general anesthesia.

  Recruiting Assistance Publique - Hôpitaux de Paris · Créteil, France · NCT06965257

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.